Literature DB >> 2452381

Dystonia with marked diurnal variation associated with biopterin deficiency.

J K Fink1, N Barton, W Cohen, W Lovenberg, R S Burns, M Hallett.   

Abstract

Two pairs of siblings with severe dystonia with marked diurnal fluctuation had both reduced CSF concentration of biopterin and marked symptomatic improvement of the dystonia in response to levodopa. Whether the reduced concentration of biopterin reflects focal abiotrophy of biopterin-containing neurons or deficiency of biopterin synthesis is uncertain. A fifth individual, who had a systemic deficiency of biopterin synthesis, shared the features of reduced biopterin in CSF, marked diurnal variation in the degree of dystonia, and clinical improvement in response to levodopa. Generalized dystonia with marked diurnal fluctuation was therefore shared by the four patients in whom biopterin deficiency was limited to the CNS and the patient with systemic deficiency of biopterin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452381     DOI: 10.1212/wnl.38.5.707

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

Review 1.  Neurochemistry and defects of biogenic amine neurotransmitter metabolism.

Authors:  K Hyland
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

Review 2.  New approaches in the treatment of the dystonias.

Authors:  N Diederich; C G Goetz; C L Comella
Journal:  Klin Wochenschr       Date:  1990-10-03

Review 3.  GTP cyclohydrolase I gene, tetrahydrobiopterin, and tyrosine hydroxylase gene: their relations to dystonia and parkinsonism.

Authors:  T Nagatsu; H Ichinose
Journal:  Neurochem Res       Date:  1996-02       Impact factor: 3.996

4.  Urinary neopterin and phenylalanine loading test as tools for the biochemical diagnosis of segawa disease.

Authors:  Vincenzo Leuzzi; Claudia Carducci; Flavia Chiarotti; Daniela D'Agnano; Maria Teresa Giannini; Italo Antonozzi; Carla Carducci
Journal:  JIMD Rep       Date:  2012-04-18

5.  Dopa responsive dystonia: a treatable condition misdiagnosed as cerebral palsy.

Authors:  K Boyd; V Patterson
Journal:  BMJ       Date:  1989-04-15

6.  Successful treatment of childhood onset symptomatic dystonia with levodopa.

Authors:  N A Fletcher; P D Thompson; J W Scadding; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-08       Impact factor: 10.154

7.  Sulfamethoxazole-trimethoprim double-blind, placebo-controlled, crossover trial in Machado-Joseph disease: sulfamethoxazole-trimethoprim increases cerebrospinal fluid level of biopterin.

Authors:  T Sakai; T Matsuishi; S Yamada; H Komori; H Iwashita
Journal:  J Neural Transm Gen Sect       Date:  1995

Review 8.  Molecular biology of catecholamine-related enzymes in relation to Parkinson's disease.

Authors:  T Nagatsu; H Ichinose
Journal:  Cell Mol Neurobiol       Date:  1999-02       Impact factor: 5.046

Review 9.  Tyrosine hydroxylase and Parkinson's disease.

Authors:  J Haavik; K Toska
Journal:  Mol Neurobiol       Date:  1998-06       Impact factor: 5.590

10.  Lessons from a remarkable family with dopa-responsive dystonia.

Authors:  G Harwood; R Hierons; N A Fletcher; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.